--- title: "Know Labs, Inc. (KNWN.US)" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/KNWN.US.md" symbol: "KNWN.US" name: "Know Labs, Inc." industry: "Health Care Equipment" datetime: "2026-03-03T12:41:38.893Z" locales: - [en](https://longbridge.com/en/quote/KNWN.US.md) - [zh-CN](https://longbridge.com/zh-CN/quote/KNWN.US.md) - [zh-HK](https://longbridge.com/zh-HK/quote/KNWN.US.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/KNWN.US.md) | [繁體中文](https://longbridge.com/zh-HK/quote/KNWN.US.md) # Know Labs, Inc. (KNWN.US) ## Company Overview Know Labs, Inc., together with its subsidiaries, focuses on the development and commercialization of proprietary sensor technology by radio and microwave spectroscopy in the United States. The company involved in the identifying and measuring any material or analyte using electromagnetic energy to detect, record, identify, and measure the signature of said materials or analytes. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. | Item | Detail | |------|--------| | Industry | Health Care Equipment | | Exchange | US Market | ## Key Drivers > *AI-analyzed key factors driving this stock's performance* ## Longbridge Financial Score™: > *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge* > Updated: 1970-01-01T00:00:00.000Z **Overall: (0.00)** ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | Dividend Yield | 0.00% | - | - | - | - | ## References - [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/KNWN.US/overview.md) - [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/KNWN.US/norm.md) - [Related News](https://longbridge.com/en/quote/KNWN.US/news.md) - [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/KNWN.US/filings.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**